Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor.

Wiley SR, Winkles JA.

Cytokine Growth Factor Rev. 2003 Jun-Aug;14(3-4):241-9. Review.

PMID:
12787562
2.

TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease.

Burkly LC, Michaelson JS, Hahm K, Jakubowski A, Zheng TS.

Cytokine. 2007 Oct;40(1):1-16. Epub 2007 Nov 5. Review.

PMID:
17981048
3.

TWEAK and Fn14: new molecular targets for cancer therapy?

Winkles JA, Tran NL, Berens ME.

Cancer Lett. 2006 Apr 8;235(1):11-7. Review.

PMID:
15885893
4.

Role of TWEAK and Fn14 in tumor biology.

Winkles JA, Tran NL, Brown SA, Stains N, Cunliffe HE, Berens ME.

Front Biosci. 2007 Jan 1;12:2761-71. Review.

PMID:
17127278
5.

TWEAK and Fn14. New players in the pathogenesis of atherosclerosis.

Blanco-Colio LM, Martín-Ventura JL, Munoz-Garcia B, Moreno JA, Meilhac O, Ortiz A, Egido J.

Front Biosci. 2007 May 1;12:3648-55. Review.

PMID:
17485328
6.

Tweak and FN14 in central nervous system health and disease.

Yepes M.

Front Biosci. 2007 May 1;12:2772-81. Review.

PMID:
17485258
7.

Inhibition of TWEAK activity as a new treatment for inflammatory and degenerative diseases.

Yepes M, Winkles JA.

Drug News Perspect. 2006 Dec;19(10):589-95. Review.

PMID:
17299600
8.

The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity.

Campbell S, Michaelson J, Burkly L, Putterman C.

Front Biosci. 2004 Sep 1;9:2273-84. Review.

PMID:
15353286
9.

TWEAK and the central nervous system.

Yepes M.

Mol Neurobiol. 2007 Jun;35(3):255-65. Review.

PMID:
17917114
10.

TWEAKing renal injury.

Sanz AB, Moreno JA, Sanchez-Nino MD, Ucero AC, Benito A, Santamaria B, Justo P, Izquierdo MC, Egido J, Blanco-Colio LM, Ortiz A.

Front Biosci. 2008 Jan 1;13:580-9. Review.

PMID:
17981571
11.

Considering TWEAK as a target for therapy in renal and vascular injury.

Ortiz A, Sanz AB, Muñoz García B, Moreno JA, Sánchez Niño MD, Martín-Ventura JL, Egido J, Blanco-Colio LM.

Cytokine Growth Factor Rev. 2009 Jun;20(3):251-8. doi: 10.1016/j.cytogfr.2009.05.002. Epub 2009 May 30. Review.

PMID:
19482507
12.

TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses.

Burkly LC, Michaelson JS, Zheng TS.

Immunol Rev. 2011 Nov;244(1):99-114. doi: 10.1111/j.1600-065X.2011.01054.x. Review.

PMID:
22017434
13.

Role of tumor necrosis factor-like weak inducer of apoptosis (TWEAK)/fibroblast growth factor-inducible 14 (Fn14) axis in rheumatic diseases.

Zhu LX, Zhang HH, Mei YF, Zhao YP, Zhang ZY.

Chin Med J (Engl). 2012 Nov;125(21):3898-904. Review.

PMID:
23106895
14.

Therapeutic targeting of TWEAK/Fnl4 in cancer: exploiting the intrinsic tumor cell killing capacity of the pathway.

Michaelson JS, Burkly LC.

Results Probl Cell Differ. 2009;49:145-60. doi: 10.1007/400_2008_18. Review.

PMID:
19513634
15.

TWEAK, a multifunctional cytokine in kidney injury.

Sanz AB, Sanchez-Niño MD, Ortiz A.

Kidney Int. 2011 Oct;80(7):708-18. doi: 10.1038/ki.2011.180. Epub 2011 Jun 22. Review.

16.

Role of the TWEAK/Fn14 pathway in autoimmune diseases.

Xu WD, Zhao Y, Liu Y.

Immunol Res. 2016 Feb;64(1):44-50. doi: 10.1007/s12026-015-8761-y. Review.

PMID:
26659091
17.

TWEAK as a target for therapy in systemic lupus erythematosus.

Leng RX, Pan HF, Qin WZ, Wang C, Chen LL, Tao JH, Ye DQ.

Mol Biol Rep. 2011 Jan;38(1):587-92. doi: 10.1007/s11033-010-0144-9. Epub 2010 Apr 1. Review.

PMID:
20358293
18.

A further TWEAK to multiple sclerosis pathophysiology.

Nazeri A, Heydarpour P, Sadaghiani S, Sahraian MA, Burkly LC, Bar-Or A.

Mol Neurobiol. 2014 Feb;49(1):78-87. doi: 10.1007/s12035-013-8490-y. Epub 2013 Jul 20. Review.

PMID:
23873135
19.

TWE-PRIL; a fusion protein of TWEAK and APRIL.

Kolfschoten GM, Pradet-Balade B, Hahne M, Medema JP.

Biochem Pharmacol. 2003 Oct 15;66(8):1427-32. Review.

PMID:
14555217
20.

Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy.

Almasan A, Ashkenazi A.

Cytokine Growth Factor Rev. 2003 Jun-Aug;14(3-4):337-48. Review.

PMID:
12787570

Supplemental Content

Support Center